There's buzz around certain type 2 diabetes drugs, which not only help regulate blood sugar but can also lead to significant ...

Grapefruit can interact with many medications, potentially affecting the way they work or increasing side effects. Some of ...

The FDA removed Wegovy, Ozempic, Mounjaro, and Zepbound from its drug shortage list for the first time in two years. The move ...

Novo Nordisk addresses safety concerns surrounding compounded versions of its weight-loss and diabetes drugs, including ...

Medically reviewed by Suzanne Fisher, RD If you’re one of the 85% of American adults who drink alcohol, whether occasionally ...

In interviews with Reuters, eight U.S. obesity specialists at universities and large health systems described a different ...

After years in shortage, weight loss and diabetes drugs Ozempic and Wegovy are now considered to be “available” by the Food ...

SGLT2 inhibitors and GLP-1 receptor agonists exhibit renoprotective effects in patients with CKD with and without diabetes.

Analysts have struggled to estimate the size of the compounded market for weight-loss drugs because their sale is not tracked ...

At the center of this fight is how the FDA regulates a possible "functional cure" for Type 1 diabetes and determines who gets ...

Mumbai: A year-long study on managing type 2 diabetes (T2D) was published in the latest edition ... reducing dependency on ...

Mounjaro, which treats type 2 diabetes, has recently been approved for weight ... Any member of the public or health ...